Skip to content
Friday, September 18, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Judicial reform 2.0: How Netanyahu’s plans to reshape the courts could affect Israel’s democracy September 18, 2026
  • Listen — A poem for Parsha Ha’Azinu September 17, 2026
  • Robert Kraft pledged $2M to aid Palestinians amid Macklemore row. How will he do it? September 17, 2026
  • Jerusalem Reform synagogue egged in second attack in a month September 17, 2026
  • Sweden’s center-left wins tight election marred by antisemitism accusations September 17, 2026
  • ACF Report Reveals the Strongest – and Most Concerning – Campuses for Jewish and Pro-Israel Students September 16, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.